Literature DB >> 14567006

Erectile dysfunction: etiology and treatment in young and old patients.

Syed H Tariq1, Usman Haleem, Mohammad L Omran, Fran E Kaiser, H Mitchell Perry, John E Morley.   

Abstract

This study shows that endocrine and vascular etiologies of erectile dysfunction are more common in the older age group, whereas depression and marital discord are more common in the younger age group. There is considerable overlap between various factors pointing to the multifactorial nature of erectile dysfunction. Review of the treatment option chosen reveals that the invasive modalities were least common as compared with the popular vacuum tumescence device (although cumbersome) and testosterone replacement. Persons with low testosterone have an improved efficacy of sildenafil when hypogonadism is treated. Sildenafil with its ease of administration and high efficacy seems to be the logical first choice for most of the patients. If contraindications exist or treatment failures occur, other treatment options should be offered to patients.

Entities:  

Mesh:

Year:  2003        PMID: 14567006     DOI: 10.1016/s0749-0690(02)00103-9

Source DB:  PubMed          Journal:  Clin Geriatr Med        ISSN: 0749-0690            Impact factor:   3.076


  3 in total

Review 1.  Andropause: is the emperor wearing any clothes?

Authors:  S H Tariq; M T Haren; M J Kim; J E Morley
Journal:  Rev Endocr Metab Disord       Date:  2005-05       Impact factor: 6.514

2.  Comparison of the simplified International Index of Erectile Function (IIEF-5) in patients of erectile dysfunction with different pathophysiologies.

Authors:  Zhengyan Tang; Dongjie Li; Xiaobo Zhang; Lu Yi; Xiangsheng Zhu; Xiangyang Zeng; Yuxin Tang
Journal:  BMC Urol       Date:  2014-07-05       Impact factor: 2.264

3.  Is mild erectile dysfunction associated with severe psychological symptoms in Chinese patients with moderate-to-severe chronic prostatitis/chronic pelvic pain syndrome?

Authors:  Xiu-Cheng Li; Xiao-Bo Zhang; Zhang-Cheng Liao; Zheng-Yan Tang; Dong-Jie Li
Journal:  Asian J Androl       Date:  2021 May-Jun       Impact factor: 3.285

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.